Stockreport

Insilico signs US$888 million AI drug-development deal days after Hong Kong IPO [Yahoo! Finance]

HONG KONG EX&CL UNSP/ADR  (HKXCY) 
NASDAQ:AMEX Investor Relations: hkexgroup.com/investor-relations?sc_lang=en
PDF Insilico's proprietary artificial intelligence platform to discover and develop novel cancer drugs. The deal comes just days after the US company's shares debuted foll [Read more]